Citadel Advisors’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Buy |
|
|||||
|
2025
Q1 | $26 | Sell |
|
|||||
|
2024
Q4 | $13.1K | Sell |
|
|||||
|
2024
Q3 | $31.5K | Sell |
|
|||||
|
2024
Q2 | $120K | Buy |
|
|||||
|
2024
Q1 | $141K | Sell |
|
|||||
|
2023
Q4 | $407K | Sell |
|
|||||
|
2023
Q3 | $927K | Buy |
|
|||||
|
2023
Q2 | $166K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $110K | Buy |
|
|||||
|
2022
Q3 | $104K | Sell |
|
|||||
|
2022
Q2 | $572K | Buy |
|
|||||
|
2022
Q1 | $352K | Sell |
|
|||||
|
2021
Q4 | $1.73M | Buy |
|
|||||
|
2021
Q3 | $453K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $845K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.34M | Buy |
|